Select data courtesy of the U.S. National Library of Medicine.

© 2026 DeepDyve, Inc. All rights reserved.

This site is protected by VikingCloud's Trusted Commerce program

    Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease.

    Li, Xiaoling; Zhang, Junjie; Wei, Bo; Tong, Huan
    Frontiers in Pharmacology·Apr 13, 2026

    Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease.

    Abstract

    Nonalcoholic fatty liver disease (NAFLD) has become a major public health concern. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor transcription factors. PPARs are categorized into three subtypes: PPARα, β/δ, and γ. Three subtypes of PPARs play crucial roles in lipid and glucose metabolism, inflammation and fibrosis. This review summarizes randomized controlled trials on the use of PPAR agonists in the treatment of NAFLD. PPARα and PPARβ/δ agonists control circulatory lipids well, but they do not yield enough liver benefits. PPARγ agonists, particularly pioglitazone, are recommended for NAFLD treatment. PPARα/γ agonists and PPARα/β/γ agonists are plausible in the treatment of NAFLD. More clinical studies are still in need to properly unveil the efficacy of PPAR agonists in the treatment of NAFLD.

    Meet DeepDyve

    Get unlimited, instant access to over 150 million full-text scientific articles for less than the price of buying a single PDF.

    150M+Research Papers
    35M+Full-Text Streaming Papers
    25M+Open Access Papers
    $2/dayStarting Price
    DeepDyve Collection

    DeepDyve Collection

    Access top-tier journals without the top-tier price. We partner directly with the world’s leading academic publishers to bring you legally compliant, instant access. Read the latest findings from Springer, Wiley, Oxford University Press, and more—all in one subscription.

    Browse our collection of titles from leading publishers

    arXiv
    ChemRxiv
    Hindawi
    JAMA
    MDPI
    medRxiv
    NEJM
    Oxford University Press
    PLOS
    PubMed
    Sage
    Springer Nature
    Wiley
    Wolters Kluwer
    AI Research Assistant

    AI Research Assistant

    Accelerate your research with our advanced AI tools. Chat directly with your uploaded papers, and DeepDyve’s 50M+ LitStream and OA collections of full-text papers. AI responses come directly from the literature, footnoted and sourced, to provide the most authoritative and verifiable responses. AI outputs powered by OpenAI and Anthropic Claude. AI Smart Folders (coming soon)

    Stop wasting time on paywalls, pirated sites and scattered journal portals

    Streamline your research workflow with DeepDyve's comprehensive literature management solution for less than the price of buying a single PDF.

    Try 1 month for $0